Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization Sort descending
Nov
15
2022
EPA Announces the Addition of Chitosan to the List of Active Ingredients Eligible for Risk Pesticide Exemption Bergeson & Campbell, P.C.
Aug
16
2019
BRAG Biobased Products Blog: August 16, 2019 Bergeson & Campbell, P.C.
Nov
30
2022
USDA Scientists Produce Nanobodies in Plant Cells that Block Emerging Pathogens Bergeson & Campbell, P.C.
Aug
23
2019
BRAG Biobased Products Blog: August 23, 2019 Bergeson & Campbell, P.C.
Jan
10
2023
BETO Announces New Notice of Intent for Improving Bioenergy Feedstocks and Optimizing Production of Biofuels and Biochemicals Bergeson & Campbell, P.C.
Sep
13
2019
CDC Seeks Additional Comment on Proposed NIOSH Project That Will Survey Engineered Nanomaterial Occupational Safety and Health Practices Bergeson & Campbell, P.C.
Jan
17
2023
EPA’s Fall 2022 Unified Agenda Includes Proposed and Final TSCA and TRI Rules Bergeson & Campbell, P.C.
Mar
7
2023
EPA Announces Both EPA and FDA to Conduct Virtual Public Meeting and Request Comments on Modernizing Their Approach to Oversight of Certain Products Bergeson & Campbell, P.C.
Nov
8
2019
House Committee Will Hold Hearing On Future Science In EPA Rulemaking Bergeson & Campbell, P.C.
Nov
14
2019
House Committee Holds Hearing on the Future of Science in EPA Rulemaking Bergeson & Campbell, P.C.
Nov
19
2019
NNI Announces Launch of Nanotechnology Entrepreneurship Network Bergeson & Campbell, P.C.
May
1
2023
EPA Denies Petition Seeking TSCA Section 4 Testing of PVA Bergeson & Campbell, P.C.
Jan
17
2020
OEHHA Adopts Amendments to Prop 65 Retail Seller Responsibilities Bergeson & Campbell, P.C.
Jun
6
2023
HSE Proposes to Include Substances in UK REACH Substance Evaluation Rolling Action Plan Bergeson & Campbell, P.C.
Jun
30
2023
Biden Administration Announces Funding for Homegrown Biofuels under Inflation Reduction Act Bergeson & Campbell, P.C.
Mar
18
2016
Biotechnology: Academies to Study Future Products of Biotechnology Bergeson & Campbell, P.C.
Feb
28
2020
Proposed Supplemental SNUR Would Remove Exemption for LCPFAC Chemical Substances Used as Surface Coatings on Articles Bergeson & Campbell, P.C.
Mar
6
2020
EPA Releases List of Disinfectants for Use against COVID-19 Bergeson & Campbell, P.C.
Apr
26
2020
SAB to Review EPA Research on Large Scale Disinfection of COVID-19 Virus Bergeson & Campbell, P.C.
Apr
29
2020
EPA and CBP Announce the Prevention of Shipments of Unregistered “Virus Shut Out” Product Imported into California Bergeson & Campbell, P.C.
May
22
2020
U.S. Air Force Synthetic Biology Challenge Deadline Approaches Bergeson & Campbell, P.C.
Sep
21
2016
White House Releases Proposed Update to the Coordinated Framework and National Strategy for Modernizing the Regulatory System for Biotechnology Products Bergeson & Campbell, P.C.
Dec
6
2023
White House OSTP and NNCO Announce Series of Events in Celebration of 20th Anniversary of the Authorization of the NNI Bergeson & Campbell, P.C.
Jun
5
2020
DOE EERE Announces Workshop On Tools To Accelerate Scaling-Up Of Biobased Fuels Bergeson & Campbell, P.C.
Oct
28
2016
Comment Deadline Approaches On Update To The Coordinated Framework For The Regulation Of Biotechnology Bergeson & Campbell, P.C.
Jan
9
2024
Malta Initiative Survey on OECD Test Guidelines and Guidance Documents Will Close January 12 Bergeson & Campbell, P.C.
Feb
23
2024
ECHA Begins Public Consultation on Recommending Authorization for Five SVHCs and Adding a New Hazard to DBP Bergeson & Campbell, P.C.
Feb
28
2017
NIOSH Publishes Draft Chapter on Analysis of Carbon Nanotubes and Nanofibers on Filters by Transmission Electron Microscopy Bergeson & Campbell, P.C.
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins